AI/MLBio Tech/Life SciencesHealth and wellnessHealthtechDigital healthB2B2C1-5 employees
First-Time Founder
Female FounderActively RaisingAbout
AI/ML driven early cancer detection test, starting with liver cancer and now expanding to multi-cancer early detection. Our patent pending platform operates on the "Sequence once, Analyze many times" paradigm - meaning we extract multiple orthogonal signals from a single wet-lab sequencing assay to generate more accurate predictions than 10x larger competitors. We are NIH/NCI SBIR funded and in validation studies with UT Southwestern (active) and Veterans Affairs (planned).